FDA Label for Sennosides
View Indications, Usage & Precautions
Sennosides Product Label
The following document was submitted to the FDA by the labeler of this product Marlex Pharmaceuticals Inc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient (In Each Tablet)
Sennosides 8.6 mg
Purpose
Laxative
Uses
- relieves occasional constipation (irregularity) generally
- produces a bowel movement in 6-12 hours
Do Not Use
- laxative products for longer than 1 week unless directed by a doctor
Ask A Doctor Before Use If You Have
- stomach Pain
- Nausea
- Vomiting
- noticed a sudden change in bowel habits that continues over a period of 2 weeks
Stop Use And Ask A Doctor If
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
If Pregnant Or Breast-Feeding,
ask a health professional before use.
Keep Out Of Reach Of Children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- take preferably at bedtime or as directed by a doctor
age | starting dosage | maximum dosage |
adults and children 12 years of age and older | 2 tablets once a day | 4 tablets twice a day |
children 6 to under 12 years of age | 1 tablet once a day | 2 tablets twice a day |
children 2 to under 6 years of age | 1/2 tablet once a day | 1 tablet twice a day |
children under 2 years | ask a doctor | ask a doctor |
Other Information
- Each tablet contains: Calcium 4mg, Sodium 3mg
- Store at 20°C to 25°C (68°F to 77°F) excursions permitted between 15° to 30°C (59°-86°F).
Inactive Ingredients
Colloidal silicon dioxide, croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, stearic acid
*Compare to Senokot®
Product color may vary slightly due to nature of ingredients.
*Marlex Pharmaceuticals, Inc. is not affiliated with the owner of the registered trademark Senokot®.
Principal Display Panel
NDC 10135-0314-01
Sennosides
8.6 mg
100 TABLETS
* Please review the disclaimer below.